Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition

Figure Injectable Drug Delivery Picture

• 1.1.2 Specifications

Table Product Specifications of Injectable Drug Delivery

• 1.2 Market Segment
  • 1.2.1 by Type

Table Products Segment of Injectable Drug Delivery

Table Global Injectable Drug Delivery Market by Type, 2011-2022 (USD Million)

• 1.2.1.1 Analgesics

Table Analgesics Overview

• 1.2.1.2 Antibiotics

Table Antibiotics Overview

• 1.2.1.3 Immunosuppressive Agents

Table Immunosuppressive Agents Overview

• 1.2.1.4 Antihypertensive Agents

Table Antihypertensive Agents Overview

• 1.2.2 by Application

Table Application Segment of Injectable Drug Delivery

Table Global Injectable Drug Delivery Market by Application, 2011-2022 (USD Million)

• 1.2.2.1 Aesthetics

Table Aesthetics Overview

• 1.2.2.2 Autoimmune Diseases

Table Autoimmune Diseases Overview

• 1.2.2.3 Hormonal Disorders

Table Hormonal Disorders Overview

• 1.2.2.4 Infectious Diseases

Table Infectious Diseases Overview

• 1.2.2.5 Oncology

Table Oncology Overview

• 1.2.2.6 Pain Management

Table Pain Management Overview

• 1.2.3 by Regions

Table Global Injectable Drug Delivery Market by Region, 2011-2022 (USD Million)

2 Industry Chain

• 2.1 Industry Chain Structure

Figure Industry Chain Structure of Injectable Drug Delivery

• 2.2 Upstream

Table Cost of Injectable Drug Delivery

Figure Manufacturing Process of Injectable Drug Delivery

• 2.3 Market
  • 2.3.1 SWOT

Figure SWOT of Injectable Drug Delivery

• 2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

• 3.1 Policy

Table Policy of Injectable Drug Delivery

• 3.2 Economic

Table GDP of Major Countries

• 3.3 Technology

Table Technology of Injectable Drug Delivery

• 3.4 Market Entry

Table Market Entry of Injectable Drug Delivery

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Analgesics Market, 2013-2018

Figure Analgesics Market Size and Growth, 2012-2018 (USD Million)

Figure Analgesics Market Size and Growth, 2012-2018 (in Volume)

Table Analgesics CAGR by Revenue and Volume, 2012-2018

• 4.1.2 Antibiotics Market, 2013-2018

Figure Antibiotics Market Size and Growth, 2012-2018 (USD Million)

Figure Antibiotics Market Size and Growth, 2012-2018 (in Volume)

Table Antibiotics CAGR by Revenue and Volume, 2012-2018

• 4.1.3 Immunosuppressive Agents Market, 2013-2018

Figure Immunosuppressive Agents Market Size and Growth, 2012-2018 (USD Million)

Figure Immunosuppressive Agents Market Size and Growth, 2012-2018 (in Volume)

Table Immunosuppressive Agents CAGR by Revenue and Volume, 2012-2018

• 4.1.4 Antihypertensive Agents Market, 2013-2018

Figure Antihypertensive Agents Market Size and Growth, 2012-2018 (USD Million)

Figure Antihypertensive Agents Market Size and Growth, 2012-2018 (in Volume)

Table Antihypertensive Agents CAGR by Revenue and Volume, 2012-2018

• 4.2 Market Forecast
  • 4.2.1 Analgesics Market Forecast, 2020-2025

Figure Analgesics Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Analgesics Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Analgesics CAGR by Revenue and Volume, 2012-2024

• 4.2.2 Antibiotics Market Forecast, 2020-2025

Figure Antibiotics Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Antibiotics Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Antibiotics CAGR by Revenue and Volume, 2012-2024

• 4.2.3 Immunosuppressive Agents Market Forecast, 2020-2025

Figure Immunosuppressive Agents Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Immunosuppressive Agents Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Immunosuppressive Agents CAGR by Revenue and Volume, 2012-2024

• 4.2.4 Antihypertensive Agents Market Forecast, 2020-2025

Figure Antihypertensive Agents Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Antihypertensive Agents Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Antihypertensive Agents CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Aesthetics Market, 2013-2018

Figure Aesthetics Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Aesthetics CAGR by Revenue and Volume, 2012-2018

• 5.1.2 Autoimmune Diseases Market, 2013-2018

Figure Autoimmune Diseases Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Autoimmune Diseases CAGR by Revenue and Volume, 2012-2018

• 5.1.3 Hormonal Disorders Market, 2013-2018

Figure Hormonal Disorders Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Hormonal Disorders CAGR by Revenue and Volume, 2012-2018

• 5.1.4 Infectious Diseases Market, 2013-2018

Figure Infectious Diseases Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Infectious Diseases CAGR by Revenue and Volume, 2012-2018

• 5.1.5 Oncology Market, 2013-2018

Figure Oncology Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Oncology CAGR by Revenue and Volume, 2012-2018

• 5.1.6 Pain Management Market, 2013-2018

Figure Pain Management Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Pain Management CAGR by Revenue and Volume, 2012-2018

• 5.2 Market Forecast
  • 5.2.1 Aesthetics Market Forecast, 2020-2025

Figure Aesthetics Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Aesthetics Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Aesthetics CAGR by Revenue and Volume, 2020-2025

• 5.2.2 Autoimmune Diseases Market Forecast, 2020-2025

Figure Autoimmune Diseases Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Autoimmune Diseases Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Autoimmune Diseases CAGR by Revenue and Volume, 2020-2025

• 5.2.3 Hormonal Disorders Market Forecast, 2020-2025

Figure Hormonal Disorders Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Hormonal Disorders Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Hormonal Disorders CAGR by Revenue and Volume, 2020-2025

• 5.2.4 Infectious Diseases Market Forecast, 2020-2025

Figure Infectious Diseases Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Infectious Diseases Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Infectious Diseases CAGR by Revenue and Volume, 2020-2025

• 5.2.5 Oncology Market Forecast, 2020-2025

Figure Oncology Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Oncology Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Oncology CAGR by Revenue and Volume, 2020-2025

• 5.2.6 Pain Management Market Forecast, 2020-2025

Figure Pain Management Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Pain Management Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Pain Management CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018

  Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)

  Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)

  Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018

  • 6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

• 6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

• 6.1.2 North America
  • 6.1.2.1 North America Market, 2012-2018

Figure North America Market Size and Growth, 2012-2018 (USD Million)

Figure North America Market Size and Growth, 2012-2018 (in Volume)

Table North America CAGR by Revenue and Volume, 2012-2018

• 6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

• 6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

• 6.1.3 Europe
  • 6.1.3.1 Europe Market, 2012-2018

Figure Europe Market Size and Growth, 2012-2018 (USD Million)

Figure Europe Market Size and Growth, 2012-2018 (in Volume)

Table Europe CAGR by Revenue and Volume, 2012-2018

• 6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

• 6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

• 6.1.4 South America
  • 6.1.4.1 South America Market, 2012-2018

Figure South America Market Size and Growth, 2012-2018 (USD Million)

Figure South America Market Size and Growth, 2012-2018 (in Volume)

Table South America CAGR by Revenue and Volume, 2012-2018

• 6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

• 6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

• 6.1.5 Middle East & Africa
  • 6.1.5.1 Middle East & Africa Market, 2012-2018

Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018

• 6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

• 6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

• 6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

• 6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

• 6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

• 6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

• 7.1 Global Market by Vendors

Table Global Injectable Drug Delivery Market by Vendors, 2012-2018 (in Volume)

Table Global Injectable Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)

Table Global Injectable Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)

• 7.2 Market Concentration

Figure Injectable Drug Delivery Market Concentration by Region

• 7.3 Price & Factors

Table Price Factors List

• 7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

• 8.1 Becton

Table Becton Profile List

Table Microecological Modulator Operating Data of Becton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.2 Dickinson and Company

Table Dickinson and Company Profile List

Table Microecological Modulator Operating Data of Dickinson and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.3 Baxter International

Table Baxter International Profile List

Table Microecological Modulator Operating Data of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.4 Gerresheimer

Table Gerresheimer Profile List

Table Microecological Modulator Operating Data of Gerresheimer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.5 Pfizer

Table Pfizer Profile List

Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.6 Schott

Table Schott Profile List

Table Microecological Modulator Operating Data of Schott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.7 Sandoz

Table Sandoz Profile List

Table Microecological Modulator Operating Data of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.8 Teva Pharmaceutical Industries

Table Teva Pharmaceutical Industries Profile List

Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.9 Eli Lilly and Company

Table Eli Lilly and Company Profile List

Table Microecological Modulator Operating Data of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.10 Antares Pharma

Table Antares Pharma Profile List

Table Microecological Modulator Operating Data of Antares Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.11 Eli Lilly & Company

Table Eli Lilly & Company Profile List

Table Microecological Modulator Operating Data of Eli Lilly & Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.12 Hospira

Table Hospira Profile List

Table Microecological Modulator Operating Data of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.13 Novo Nordik

Table Novo Nordik Profile List

Table Microecological Modulator Operating Data of Novo Nordik (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.14 Sanofi

Table Sanofi Profile List

Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.15 Terumo Corporation

Table Terumo Corporation Profile List

Table Microecological Modulator Operating Data of Terumo Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.16 Unilife Corporation

Table Unilife Corporation Profile List

Table Microecological Modulator Operating Data of Unilife Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.17 Zogenix

Table Zogenix Profile List

Table Microecological Modulator Operating Data of Zogenix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.18 Scandinavian Health

Table Scandinavian Health Profile List

Table Microecological Modulator Operating Data of Scandinavian Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

Summary

Injectable drug delivery is defined as administration of a drug or drugs directly into patient’s blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.
The global Injectable Drug Delivery market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Analgesics
Antibiotics
Immunosuppressive Agents
Antihypertensive Agents
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Becton
Dickinson and Company
Baxter International
Gerresheimer
Pfizer
Schott
Sandoz
Teva Pharmaceutical Industries
Eli Lilly and Company
Antares Pharma
Eli Lilly & Company
Hospira
Novo Nordik
Sanofi
Terumo Corporation
Unilife Corporation
Zogenix
Scandinavian Health
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Aesthetics
Autoimmune Diseases
Hormonal Disorders
Infectious Diseases
Oncology
Pain Management
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa